Search clinical trials for: Polyamine Transport Inhibitor AMXT-1501 Dicaprate

Total 126 results

Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

Malignant Glioma | Diffuse Glioma

United States
Cingulate Therapeutics

Recruiting

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit Hyperactivity

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

Healthy

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Completed

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Anemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic Syndrome

United States
Cingulate Therapeutics
Premier Research Group plc

Active, not recruiting

Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301

ADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit Hyperactivity

United States
Boehringer Ingelheim

Completed

A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin

Diabetes Mellitus, Type 2

China
Oregon Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Development of a Family-Based Treatment for Adolescent Methamphetamine Use (AIMS)

Behavior and Mental Disorders | Methamphetamine Disorders

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

Healthy

United States
Sadat City University

Recruiting

Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis

Ulcerative Colitis

Egypt
Cingulate Therapeutics
Rho, Inc.

Completed

Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.

ADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined

United States
Sandoz

Completed

A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions

Depression
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions

Healthy

United States
University of Oxford
Janssen Research & Development, LLC

Completed

Effects of Bupropion in Depression

Depression

United Kingdom
East Tennessee State University

Completed

Bupropion and Restless Legs Syndrome

Restless Legs Syndrome

United States
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Bupropion

Healthy

United Kingdom
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Craving, Binge Eating and Obesity

Obesity | Binge Eating Disorder

United States
Chi-Un Pae
GlaxoSmithKline

Completed

Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features (WellbutrinXL)

Depressive Disorder, Major

Korea, Republic of
University Hospital, Basel, Switzerland

Recruiting

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects (LBL)

Healthy

Switzerland
Yale University

Terminated

Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET

Cocaine Dependence

United States
Altschuler, Eric, M.D.
GlaxoSmithKline

Completed

A Trial of Wellbutrin for Crohn's Disease

Crohn Disease

United States
Washington University School of Medicine

Completed

Clinical Study of Generic and Brand Bupropion in Depression (BALANCE)

Major Depressive Disorder

United States
Novartis Pharmaceuticals

Completed

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure

Heart Failure

Germany, Lithuania
Todd M Koelling, MD
scPharmaceuticals, Inc.

Withdrawn

A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen (DIVERSION-HF)

Acute Decompensated Heart Failure

United States
Jan Kochanowski University

Recruiting

Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure

Heart Failure

Poland
Janssen Research & Development, LLC

Completed

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

Healthy

United States
Alexandria University

Recruiting

Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome

Polycystic Ovary Syndrome (PCOS)

Egypt
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence

Substance Abuse | Cocaine Dependence

United States
Yale University
Sunovion

Terminated

Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban

Insomnia | Nicotine Dependence

United States
University of Minnesota
National Institute on Drug Abuse (NIDA); Pfizer

Completed

Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence (ChanBan)

Nicotine Dependence | Nicotine Withdrawal

United States
Yu-Li Hospital
National Health Research Institutes, Taiwan; Department of Health, Executive...

Completed

The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia (PSIAARP)

Schizophrenia | Tobacco Dependence

Taiwan
Queen's University
Eli Lilly and Company

Completed

An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients

Depressive Disorder | Depression | Bipolar Disorder

Canada
Janssen Research & Development, LLC

Completed

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components

Healthy Volunteers

United States
Johns Hopkins University
scPharmaceuticals, Inc.

Completed

Sub-Q Versus IV Furosemide in Acute Heart Failure

Congestive Heart Failure

United States
Organon and Co

Completed

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)

Schizophrenia
Janssen Research & Development, LLC

Completed

An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy

Diabetes Mellitus, Type 2

United States, Romania, Canada, Russian Federation, Czech Republic, Slovakia, Mexico
Cingulate Therapeutics

Completed

CTx-1301 Comparative Bioavailability Study

ADHD

United States
University of Minnesota
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Varenicline and Smoking Cessation in Schizophrenia (VSCS)

Smoking Cessation | Schizophrenia

United States
NRG Oncology
National Cancer Institute (NCI)

Completed

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Breast Carcinoma | Cervical Carcinoma | Vaginal Carcinoma | Ovarian Carcinoma | Uterine Corpus Cancer | Vulvar Carcinoma | Postmenopausal

United States
Alto Neuroscience

Withdrawn

Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion (LEAP-DB)

Major Depressive Disorder
Organon and Co
Pfizer

Completed

3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

Bipolar Disorder
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

Hypertension
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Depression | Suicidal Ideation

United States
Vanderbilt University Medical Center

Completed

Aldosterone and the Metabolic Syndrome

Glucose Metabolism Disorders | Metabolic Diseases | Diabetes Mellitus | Endocrine System Diseases

United States
University of Bari

Recruiting

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. (THD-HP)

Helicobacter Pylori Infection | Antibiotic Resistant Infection | Antibiotic Resistant Strain

Italy
US Department of Veterans Affairs
Janssen, LP

Completed

The Effects of Risperidone and Olanzapine on Thinking

Psychotic Disorders | Schizophrenia

United States
Minerva Neurosciences

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Negative Symptoms in Schizophrenia

United States
Amani Hassan Abdel-Wahab

Completed

Olanzapine for the Prevention of Postoperative Nausea and Vomiting

Postoperative Nausea

Egypt
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Pharmacodynamic Study of Once-Daily and Twice-Daily Dosing With Canagliflozin in Healthy Adult Volunteers

Healthy

Search clinical trials for: Polyamine Transport Inhibitor AMXT-1501 Dicaprate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations